InsidersTradesSigma
Total declarations
Companies
▲ Purchases (6 ops.)
▼ Sales (1 ops.)
Insider track record
CEODisclosed buys
6
Disclosed sells
1
T+90 hit rate
100%
T+90 mean return
+25.4%
Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the full record of transactions filed by Todisco Joseph, Chairman & CEO. Director active across 3 companies, notably Amneal Pharmaceuticals, Inc.. Aggregated, 26 filings have been logged. Split: 6 buys · 1 sell. Total volume traded: €233k. History available since 2 December 2021. The latest transaction was disclosed on 4 February 2026 (Attribution). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to Todisco Joseph
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations26 total
77,156 shares0Common StockSEC:0001213900-26-013406:0
225,900 shares0Common StockSEC:0001213900-26-008478:0
17,417 shares@ US$7.157.0% of flowCommon StockSEC:0001213900-26-005425:0
30,000 shares@ US$4.438.0% of flowCommon StockSEC:0001213900-25-124063:0
6,397 shares0Common StockSEC:0001774807-25-000005:0
50,000 shares@ US$3.4711.3% of flowCommon StockSEC:0001213900-25-087374:0
21,225 shares@ US$11.6616.9% of flowCommon StockSEC:0001213900-25-087371:0
59,170 shares@ US$3.3819.8% of flowCommon StockSEC:0001213900-25-027598:0
187,500 shares0Common StockSEC:0001213900-25-005675:0
17,829 shares@ US$11.1920.7% of flowCommon StockSEC:0001213900-25-003534:0
26,982 shares@ US$5.1713.8% of flowCommon StockSEC:0000899140-24-000577:0
13,561 shares@ US$3.745.0% of flowCommon StockSEC:0000899140-24-000302:0
Canonical exit: 11 Jun 2024 (T+90)
133,333 shares0Common StockSEC:0000929638-24-000131:0
10,000 shares@ US$3.713.7% of flowCommon StockSEC:0000929638-23-002490:0
Canonical exit: 7 Dec 2023 (T+90)
5,000 shares@ US$4.582.3% of flowCommon StockSEC:0000929638-23-001527:0
Canonical exit: 15 Aug 2023 (T+90)
5,000 shares@ US$4.582.3% of flowCommon StockSEC:0000929638-23-001517:0
37,443 shares@ US$5.3019.3% of flowCommon StockSEC:0000929638-23-001441:0
20,000 shares@ US$3.827.9% of flowCommon StockSEC:0001213900-22-073225:0
Canonical exit: 13 Feb 2023 (T+90)
4,700 shares@ US$3.922.0% of flowCommon StockSEC:0001213900-22-050936:0
Canonical exit: 22 Nov 2022 (T+90)
10,000 shares@ US$3.380.0035% mcap100.0% of flowCommon StockSEC:0001213900-22-027450:0
Canonical exit: 14 Aug 2022 (T+90)
207,469 shares0Common StockSEC:0001213900-22-025973:0
4,442 sharesClass A Common StockSEC:0001209191-22-028164:0
11,111 sharesClass A Common StockSEC:0001209191-22-016056:0
29,684 sharesClass A Common StockSEC:0001209191-22-014150:0
1,500 shares@ US$4.10100.0% of flowClass A Common StockSEC:0001209191-21-067956:0
25 of 26 declarations
About Todisco Joseph
Todisco Joseph is Executive Vice President and Chief Executive Officer. He has 26 filings in total, and across the 26 sampled filings the buy and sell volumes are EUR 227117 and EUR 5433, with transactions from 2021-05-11 to 2026-02-06. The top filings concern CorMedix Inc., and the most frequent transaction nature is Attribution.
